Wearable Injectors Market to Grow at a CAGR of 11.6% to reach US$ 13,880.88 Million from 2020 to 2027

Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (On-Body Injectors and Off-Body Injectors); Application (Diabetes, Oncology, Cardiovascular Diseases, Autoimmune Diseases, and Other Applications); End User (Hospitals and Clinics, Homecare Setting, and Other End Users); and Geography

Publication Month: Jun 2020 | Report Code: TIPMD00002677 | No. of Pages: 184 | Category: Medical Device | Status: Published
Covid

The wearable injectors market was valued at US$ 5,791.23 million in 2019 and is projected to reach US$ 13,880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020–2027.

 

Wearable injectors are drug delivery devices adhering to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. The devices consist of a reservoir for medicine, a cannula for substance delivery to tissues, and a drive system to deliver the appropriate drug volume; it is loaded with adhesive to fix the device to the patients’ skin. The growth of the wearable injector market is attributed to the increasing chronic disease prevalence, technological advancements and design development, and conventional drug delivery system limitations, among others. However, the lack of adoption in emerging countries limits the market growth. Further, the increasing demand for biologics is a significant opportunity for the global wearable injectors market players.

 

Lucrative Regional Wearable Injectors Markets


Lucrative Regional Wearable Injectors Markets

Get more information on this report :

 

Market Insights

Technological Advancements and Design Development

Wearable injectors are rapidly gaining their prominence in the market owing to their capabilities in delivering a high volume of viscous formulations. The administration of pharmaceuticals via intravenous (IV) infusion is expensive in healthcare settings. Self-administration of subcutaneous injections is expected to save 30–70% of costs. Moreover, administration through conventional methods poses risks such as inaccurate dosage and needle stick injuries. The rise in the number of biologic drugs that are not suitable for oral administration has increased the adoption of wearable injection devices. Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods such as wearable injectors. For instance, the enFuse wearable injector manufactured by Enable Injections is used for subcutaneous delivery of high-volume therapeutics outside a healthcare facility. The company has also introduced mobile monitoring and more significant volume capabilities to its high-volume wearable injectors.

A new category of wearable products has emerged, bridging the gap between functionality and cost while improving patient safety and quality of life. One such example is Stevanato Group’s cartridge-based wearable device, currently under development, received Best Innovation in Drug Delivery Device award at Pharmapack Awards in 2019. The product includes a disposable, wearable pod, and reusable handheld controller that serves as the user interface and control unit for the pod. This is used for varied therapeutic areas, including diabetes, hormone therapies, pain management, and Alzheimer’s disease treatment. Moreover, continuous development by leading players in upgrading the existing wearable injector portfolio is further driving the demand for wearable injectors. For instance, in February 2020, BD, a leading global medical technology company, completed a human clinical trial of the BD Libertas Wearable Injector. The award-winning injector is currently in development and is designed as a subcutaneous drug delivery system to deliver biologics with viscosities up to 50 cP in 2–5 mL and 5–10 mL configurations.

 

Products Insights

Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors. In 2019, the on-body injectors segment accounted for a larger share of the global wearable injectors market. On-body injectors ensure comfort and ease of use, confer water resistance and flexible dosing features, and facilitate automatic warming of refrigerated drugs. These benefits have led to the rise in demand for on-body injectors. Moreover, the market for off-body injectors is expected to grow at a faster pace during the forecast period, and the projected growth is attributed to the fact that these devices are free of the risks of skin fitting issues and allergic skin reactions.

 

Global Wearable Injector Market, By Type – 2019 and 2027

Global Wearable Injector Market, By Type – 2019 and 2027

Get more information on this report :


 

End User Insights

Based on end user, the wearable injectors market is segmented into hospitals and clinics, homecare setting, and other end users. The homecare setting segment held the largest share in the global wearable injectors market in 2019. Growth of the market for this segment is attributed to expose to global trends, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system limitations. For instance, the home care segment is anticipated to dominate the market due to the growing inclination toward self-administration of medicine and the rising preference of low-cost healthcare procedures. Also, the increasing demand for technologically developed drug delivery options to lowers the frequency of hospital visits and requires minimal expertise. Moreover, the ease of use, and ready availability and accessibility has also increased the adoption of wearable injectors among patients. Hence, this has increased the use of drug delivery systems in in-home care settings.

 

Strategic Insights

Collaborations and technology partnerships by the players operating in the market to bridge the demand-supply gap are anticipated to play a significant role in the growth of the wearable injectors market during the forecast period. Moreover, the growing number of accidents and trauma cases, and rising incidence of infectious diseases are predicted to accelerate market growth.

 

By Type

  • On-body Injectors
  • Off-body Injectors

By Application

  • Diabetes
  • Oncology
  • Cardiovascular Disease
  • Autoimmune Disease
  • Other Applications

By End User

  • Hospitals and Clinics
  • Homecare Setting
  • Other End User

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Russia
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Amgen, Inc.
  • Medtronic
  • BD
  • Insulet Corporation
  • Gerresheimer AG (Sensile Medical)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG,
  • Tandem Diabetes Care, Inc.
  • Cequr SA
  • Debiotech S.A
  • E3D Elcam Drug Delivery Devices
  • Zealand Pharma A/S (Valeritas, Inc.)

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Wearable Injectors Market – By Type

1.3.2        Global Wearable Injectors Market – By Application

1.3.3        Global Wearable Injectors Market – By End User

1.3.4        Global Wearable Injectors Market – By Geography

2.             Wearable Injectors Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Wearable Injectors Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East & Africa– PEST Analysis

4.2.5        South & Central America – PEST Analysis

4.3       Expert Opinion

5.             Wearable Injectors Market – Industry Dynamics

5.1       Market Drivers

5.1.1        Increasing Chronic Diseases Prevalence

5.1.2        Technological Advancements and Design Development

5.1.3        Conventional Drug Delivery System Limitations

5.2       Market Restraints

5.2.1        Lack of Adoption in Emerging Countries

5.3       Market Opportunities

5.3.1        Increasing Demand for Biologics

5.4       Future Trends

5.4.1        Integration of Wearable Injectors During Early Drug Development

5.5       Impact Analysis

6.             Wearable Injectors Market – Global Analysis

6.1       Global Wearable Injectors Market Revenue Forecast and Analysis

6.2       Global Wearable Injectors Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.             Wearable Injectors Market– By Type

7.1       Overview

7.2       Wearable Injectors Market Share, by Type, 2019 and 2027 (%)

7.4       On-body Injectors

7.4.1        Overview

7.4.2        On-body Injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

7.5       Off-body Injectors

7.5.1        Overview

7.5.2        Off-body Injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.             Wearable Injectors Market– By Application

8.1       Overview

8.2       Wearable Injectors Market Share, by Application, 2019 and 2027 (%)

8.4       Oncology

8.4.1        Overview

8.4.2        Oncology: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.5       Diabetes

8.5.1        Overview

8.5.2        Diabetes: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.6       Autoimmune Disease

8.6.1        Overview

8.6.2        Autoimmune Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.7       Cardiovascular Disease

8.7.1        Overview

8.7.2        Cardiovascular Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.8       Other Applications

8.8.1        Overview

8.8.2        Other Applications: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

9.             Wearable Injectors Market– By End User

9.1       Overview

9.2       Wearable Injectors Market Share, by End user, 2019 and 2027 (%)

9.4       Homecare Setting

9.4.1        Overview

9.4.2        Homecare Setting: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

9.5       Hospitals and Clinics

9.5.1        Overview

9.5.2        Hospitals and Clinics: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

9.6       Other End Users

9.6.1        Overview

9.6.2        Other End Users: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

10.          Wearable Injectors Market – Geographic Analysis

10.1    North America: Wearable Injectors Market

10.1.1     Overview

10.1.2     North America: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4     North America Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.1.5     North America Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6     North America: Wearable Injectors Market, by Country, 2019 & 2027 (%)

10.1.7     US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3    US Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.1.7.4    US Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8     Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3    Canada Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.1.8.4    Canada Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9     Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3    Mexico Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.1.9.4    Mexico Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2    Europe: Wearable Injectors Market

10.2.1     Overview

10.2.2     Europe: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.4     Europe Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.5     Europe Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.6     Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)

10.2.7     Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1    Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    Germany Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.3    Germany Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.7.4    Germany Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.8     UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    UK Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.3    UK Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.8.4    UK Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.9     France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1    France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    France Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.3    France Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.9.4    France Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.10   Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.3 Spain Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.10.4 Spain Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.11   Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.3 Italy Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.11.4 Italy Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3    Asia Pacific: Wearable Injectors Market

10.3.1     Overview

10.3.2     Asia Pacific: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)

10.3.3     Asia Pacific Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.4     Asia Pacific Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.5     Asia Pacific Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.6     Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)

10.3.7     China: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1    China: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.2    China Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.7.3    China Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.7.4    China Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.8     Japan: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1    Japan: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2    Japan Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.8.3    Japan Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.8.4    Japan Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.9     India: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1    India: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2    India Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.9.3    India Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.9.4    India Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.10   South Korea: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 South Korea: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 South Korea Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.3 South Korea Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.10.4 South Korea Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.11   Australia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Australia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Australia Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.11.3 Australia Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.11.4 Australia Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4    Middle East & Africa: Wearable Injectors Market

10.4.1     Overview

10.4.2     Middle East & Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (US$ Million)

10.4.3     Middle East & Africa Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.4     Middle East & Africa Wearable Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)

10.4.5     Middle East & Africa Wearable Injectors Market, by End User – Revenue and Forecast to 2027  (USD Million)

10.4.6     Middle East & Africa: Wearable Injectors Market, by Country, 2018 & 2027 (%)

10.4.7     UAE: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.1    UAE: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.2    UAE Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.3    UAE Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.4.7.4    UAE Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4.8     Saudi Arabia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.1    Saudi Arabia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.2    Saudi Arabia Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.3    Saudi Arabia Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.4.8.4    Saudi Arabia Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4.9     South Africa: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.1    South Africa: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.2    South Africa Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.9.3    South Africa Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.4.9.4    South Africa Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5    South and Central America: Wearable Injectors Market

10.5.1     Overview

10.5.2     South and Central America: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.5.3     South and Central America Wearable Injectors Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.5.4     South and Central America Wearable Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)

10.5.5     South and Central America Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5.6     South and Central America: Wearable Injectors Market, by Country, 2019 & 2027 (%)

10.5.7     Brazil: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Brazil: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2    Brazil Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.3    Brazil Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.5.7.4    Brazil Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5.8     Argentina: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.1    Argentina: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2    Argentina Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.3    Argentina Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.5.8.4    Argentina Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.          Impact Of COVID-19 Pandemic on Global Wearable Injectors Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

11.2    Europe: Impact Assessment Of COVID-19 Pandemic

11.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

12.          Wearable Injectors Market –Industry Landscape

12.1    Overview

12.2    Growth Strategies Done by the Companies in the Market, (%)

12.3    Organic Developments

12.3.1     Overview

12.4    Inorganic Developments

12.4.1     Overview

13.          Company Profiles

13.1    BD

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    CeQur SA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Debiotech S.A.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    E3D Elcam Drug Delivery Devices

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Insulet Corporation

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Gerresheimer AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Tandem Diabetes Care Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Zealand Pharma A/S

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    West Pharmaceutical Services, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Ypsomed AG

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

13.11 Medtronic

13.11.1   Key Facts

13.11.2   Business Description

13.11.3   Products and Services

13.11.4   Financial Overview

13.11.5   SWOT Analysis

13.11.6   Key Developments

13.12 Amgen, Inc.

13.12.1   Key Facts

13.12.2   Business Description

13.12.3   Products and Services

13.12.4   Financial Overview

13.12.5   SWOT Analysis

13.12.6   Key Developments

14.          Appendix

14.1    About the Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             North America Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 3.             North America Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             US Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             US Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 6.             US Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             Canada Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 9.             Canada Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          Mexico Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Mexico Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 12.          Mexico Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Europe Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Europe Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 15.          Europe Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Germany Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Germany Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 18.          Germany Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          UK Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20.          UK Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 21.          UK Wearable Injectors Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 22.          France Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          France Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 24.          France Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 25.          Spain Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          Spain Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 27.          Spain Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 28.          Italy Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29.          Italy Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 30.          Italy Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          Asia Pacific Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 32.          Asia Pacific Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 33.          Asia Pacific Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 34.          China Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 35.          China Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 36.          China Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 37.          Japan Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 38.          Japan Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 39.          Japan Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 40.          India Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 41.          India Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 42.          India Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 43.          South Korea Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44.          South Korea Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 45.          South Korea Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 46.          Australia Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 47.          Australia Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 48.          Australia Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 49.          Middle East & Africa Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 50.          Middle East & Africa Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 51.          Middle East & Africa Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 52.          UAE Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 53.          UAE Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 54.          UAE Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 55.          Saudi Arabia Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 56.          Saudi Arabia Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 57.          Saudi Arabia Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 58.          South Africa Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 59.          South Africa Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 60.          South Africa Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 61.          South and Central America Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 62.          South and Central America Wearable Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 63.          South and Central America Wearable Injectors Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 64.          Brazil Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 65.          Brazil Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 66.          Brazil Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 67.          Argentina Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 68.          Argentina Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 69.          Argentina Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 70.          Organic Developments Done By Companies

Table 71.          Inorganic Developments Done By Companies

Table 72.          Glossary of Terms, Wearable Injectors Market

 

 

LIST OF FIGURES

Figure 1.           Wearable Injectors Market Segmentation

Figure 2.           Wearable Injectors Segmentation, By Region

Figure 3.           Global Wearable Injectors Market Overview

Figure 4.           On-body Injectors Segment Held Largest Share of Wearable Injectors Market

Figure 5.           Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6.           Wearable Injectors Market, by Geography (US$ Million)

Figure 7.           Global Wearable Injectors Market – Leading Country Markets (US$ Million)

Figure 8.           Global Wearable Injectors Market, Industry Landscape

Figure 9.           North America : PEST Analysis

Figure 10.        Europe: PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East & Africa PEST Analysis

Figure 13.        South & Central America PEST Analysis

Figure 14.        Wearable Injectors Market Impact Analysis of Driver and Restraints

Figure 15.        Global Wearable Injectors Market – Revenue Forecast and Analysis – 2019- 2027

Figure 16.        Global Wearable Injectors Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Wearable Injectors Market

Figure 18.        Wearable Injectors Market Share, by Type, 2019 and 2027 (%)

Figure 19.        On-body injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 20.        Off-body injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 21.        Wearable Injectors Market Share, by Application, 2019 and 2027 (%)

Figure 22.        Oncology: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 23.        Diabetes: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 24.        Autoimmune Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 25.        Cardiovascular Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 26.        Other Applications: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 27.        Wearable Injectors Market Share, by End user, 2019 and 2027 (%)

Figure 28.        Homecare Setting: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 29.        Hospitals and Clinics: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 30.        Other End Users: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

Figure 31.        North America: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 32.        North America Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 33.        North America: Wearable Injectors Market, by Country, 2019 & 2027 (%)

Figure 34.        US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Canada Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Europe: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 39.        Europe Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 40.        Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)

Figure 41.        Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 45.        Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        Asia Pacific: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 47.        Asia Pacific Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 48.        Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)

Figure 49.        China: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Japan: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        India: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 52.        South Korea: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 53.        Australia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        Middle East & Africa: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 55.        Middle East & Africa Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 56.        Middle East & Africa: Wearable Injectors Market, by Country, 2018 & 2027 (%)

Figure 57.        UAE: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        Saudi Arabia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 59.        South Africa: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 60.        South and Central America: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 61.        South and Central America Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 62.        South and Central America: Wearable Injectors Market, by Country, 2019 & 2027 (%)

Figure 63.        Brazil: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        Argentina: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 66.        Impact of COVID-19 Pandemic in European Country Markets

Figure 67.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 68.        Impact Of COVID-19 Pandemic in Rest of the World Countries Market

Figure 69.        Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Wearable Injectors Market

  1. Amgen, Inc.
  2. Medtronic
  3. BD
  4. Insulet Corporation
  5. Gerresheimer AG (Sensile Medical)
  6. West Pharmaceutical Services, Inc.
  7. Ypsomed AG,
  8. Tandem Diabetes Care, Inc.
  9. Cequr SA
  10. Debiotech S.A
  11. E3D Elcam Drug Delivery Devices
  12. Zealand Pharma A/S (Valeritas, Inc.)
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global wearable injectors market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global wearable injectors market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPMD00002677
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Wearable injectors are drug delivery devices that adhere to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. Wearable injectors consist of a reservoir for the medication, a cannula for delivery to the tissue, adhesive to fix the device to the patient’s skin, and a drive system to deliver the appropriate drug volume.

The global wearable injectors market is being driven by factors such as the increasing chronic diseases prevalence, technological advancements & design development, and conventional drug delivery system limitations. Furthermore, increasing demand for biologics is likely to offer significant opportunities for the growth of the global wearable injectors market.

The lack of adoption in emerging countries is the significant factor that will impede the wearable injectors market growth. The development of biopharmaceuticals and complex chemicals, along with novel approaches to drug delivery, is driven owing to a vast portion of the population suffering from chronic conditions across the world. In developed countries, insurance coverage helps in the adoption of innovative technologies, such as wearable injector devices, whereas, in developing countries, a large portion of the population is not able to afford necessary treatment drugs for chronic diseases.

Pricing